As the field of interventional cardiology continues to evolve, innovations in imaging and stent-free treatment methods are ...

Patients and Methods: Eighty-seven patients with peripheral occlusive arterial disease stage IIb who had been successfully treated with PTA and stent implantation were randomised to receive orally ...

Philips has now developed a device intended to integrate two forms of laser-based PAD therapy, atherectomy and intravascular ...

The results in patients with long, complex lesions are better than or equal to those of surgery, but without the ...

"By 2024, the market is projected to reach a staggering US$597.00bn worldwide. Among these markets, Medical Devices are expected to dominate, with a projected market volume of US$508.00bn by 2024.

NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact ...

Robert Wood Johnson University Hospital Rahway recently celebrated the opening of its new, state-of-the-art cardiac ...

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, "Orchestra BioMed" or the "Company"), a biomedical innovation company accelerating high-impact technologies ...

thereby requiring placement of a stent. Arterial duplex is commonly used for postintervention monitoring because of its reliability, repeatability, noninvasive nature and low cost. Computed ...

A combination of transarterial embolization and percutaneous CT-guided ablation was an effective, well-tolerated, and safe ...

Cardiovascular disease, sometimes abbreviated as CVD, is the leading cause of death worldwide. It’s a catchall term for heart ...

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - November 12, 2024) - Investorideas.com, a go-to investing platform, releases an industry snapshot looking at the future of medical ...